NASDAQ:BCAC Brookline Capital Acquisition (BCAC) Stock Price, News & Analysis → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free BCAC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$9.94▼$27.7450-Day Range$0.36▼$22.7152-Week Range$9.50▼$27.74Volume586,400 shsAverage Volume39,682 shsMarket Capitalization$153.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Brookline Capital Acquisition alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About Brookline Capital Acquisition Stock (NASDAQ:BCAC)Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.Read More Ad WealthPressA lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one BCAC Stock News HeadlinesOctober 8, 2023 | stockhouse.comQuetta Acquisition Corporation Announces Pricing of $60 Million Initial Public OfferingAugust 15, 2023 | finance.yahoo.comQ2 2023 electroCore, Inc. Earnings CallMarch 28, 2024 | Behind the Markets (Ad)The Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.May 25, 2023 | seekingalpha.comLFAC LF Capital Acquisition Corp. IIApril 6, 2023 | benzinga.comBrookline Capital Downgrades Oncternal Therapeutics to HoldDecember 30, 2022 | yahoo.comBrookline Bancorp, Inc. Announces Preliminary Results of Merger Consideration Elections Regarding Pending PCSB Financial Corporation MergerAugust 1, 2022 | finance.yahoo.comApexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology CompanyJune 29, 2022 | nz.finance.yahoo.comApexigen Announces Board Appointment and New ChairMarch 28, 2024 | Behind the Markets (Ad)The AI Defense Stock Set to SoarTo protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.June 8, 2022 | finance.yahoo.comApexigen Appoints William Duke as Chief Financial OfficerMay 9, 2022 | tmcnet.comApexigen to Host Investor Day on Antibody Therapeutic Pipeline and Unique APXiMAB™ PlatformMarch 23, 2022 | benzinga.comBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mount Rainier Acquisition Corp. (Nasdaq - RNER), Brookline Capital Acquisition Corp. (Nasdaq - BCAC), Vickers Vantage Corp. I (Nasdaq - VCKA), Pono Capital Corp (Nasdaq - PONO)March 18, 2022 | seekingalpha.comCancer focused Apexigen to go public via deal with SPAC Brookline CapitalJanuary 24, 2022 | nasdaq.comBrookline Capital Acquisition Corp. Common Stock (BCAC)August 27, 2021 | barrons.comBrookline Capital Acquisition Corp.July 26, 2021 | finance.yahoo.comBrookline Capital Markets Hosts Biotech Symposium TodaySee More Headlines Receive BCAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryN/A Current SymbolNASDAQ:BCAC CUSIPN/A CIK1814140 Webwww.brooklinecapitalacquisitioncorp.com Phone646-643-6716FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-480,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-416.32% Return on Assets-4.75% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.07 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,746,000Free Float5,451,000Market Cap$153.20 million OptionableNot Optionable Beta-0.03 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesDr. Samuel P. Wertheimer Ph.D.Chairman & CEOMr. Scott A. Katzmann (Age 66)Pres & Director Mr. Patrick SturgeonChief Financial OfficerKey CompetitorsDBV TechnologiesNASDAQ:DBVTBioAtlaNASDAQ:BCAB10X Capital Venture Acquisition Corp. IIINYSE:VCXBMolecular PartnersNASDAQ:MOLNLENZ TherapeuticsNASDAQ:LENZView All Competitors This page (NASDAQ:BCAC) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brookline Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.